These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

56 related items for PubMed ID: 14750046

  • 1. Natural course and placebo response in short-term, placebo-controlled studies in major depression: a meta-analysis of published and non-published studies.
    Storosum JG, Elferink AJ, van Zwieten BJ, van den Brink W, Huyser J.
    Pharmacopsychiatry; 2004 Jan; 37(1):32-6. PubMed ID: 14750046
    [Abstract] [Full Text] [Related]

  • 2. Does inclusion of a placebo arm influence response to active antidepressant treatment in randomized controlled trials? Results from pooled and meta-analyses.
    Sinyor M, Levitt AJ, Cheung AH, Schaffer A, Kiss A, Dowlati Y, Lanctôt KL.
    J Clin Psychiatry; 2010 Mar; 71(3):270-9. PubMed ID: 20122371
    [Abstract] [Full Text] [Related]

  • 3. Placebo response in randomized controlled trials of antidepressants for pediatric major depressive disorder.
    Bridge JA, Birmaher B, Iyengar S, Barbe RP, Brent DA.
    Am J Psychiatry; 2009 Jan; 166(1):42-9. PubMed ID: 19047322
    [Abstract] [Full Text] [Related]

  • 4. Metyrapone as additive treatment in major depression: a double-blind and placebo-controlled trial.
    Jahn H, Schick M, Kiefer F, Kellner M, Yassouridis A, Wiedemann K.
    Arch Gen Psychiatry; 2004 Dec; 61(12):1235-44. PubMed ID: 15583115
    [Abstract] [Full Text] [Related]

  • 5. Meta-analysis of placebo rates in major depressive disorder trials.
    Stolk P, Ten Berg MJ, Hemels ME, Einarson TR.
    Ann Pharmacother; 2003 Dec; 37(12):1891-9. PubMed ID: 14632596
    [Abstract] [Full Text] [Related]

  • 6. Duloxetine in the treatment of Major Depressive Disorder: a comparison of efficacy in patients with and without melancholic features.
    Mallinckrodt CH, Watkin JG, Liu C, Wohlreich MM, Raskin J.
    BMC Psychiatry; 2005 Jan 04; 5():1. PubMed ID: 15631624
    [Abstract] [Full Text] [Related]

  • 7. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
    Detke MJ, Wiltse CG, Mallinckrodt CH, McNamara RK, Demitrack MA, Bitter I.
    Eur Neuropsychopharmacol; 2004 Dec 04; 14(6):457-70. PubMed ID: 15589385
    [Abstract] [Full Text] [Related]

  • 8. Duloxetine for the treatment of major depressive disorder: safety and tolerability associated with dose escalation.
    Wohlreich MM, Mallinckrodt CH, Prakash A, Watkin JG, Carter WP.
    Depress Anxiety; 2007 Dec 04; 24(1):41-52. PubMed ID: 16845641
    [Abstract] [Full Text] [Related]

  • 9. Selegiline transdermal system in the prevention of relapse of major depressive disorder: a 52-week, double-blind, placebo-substitution, parallel-group clinical trial.
    Amsterdam JD, Bodkin JA.
    J Clin Psychopharmacol; 2006 Dec 04; 26(6):579-86. PubMed ID: 17110814
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients.
    Yevtushenko VY, Belous AI, Yevtushenko YG, Gusinin SE, Buzik OJ, Agibalova TV.
    Clin Ther; 2007 Nov 04; 29(11):2319-32. PubMed ID: 18158074
    [Abstract] [Full Text] [Related]

  • 11. Duloxetine versus escitalopram and placebo: an 8-month, double-blind trial in patients with major depressive disorder.
    Pigott TA, Prakash A, Arnold LM, Aaronson ST, Mallinckrodt CH, Wohlreich MM.
    Curr Med Res Opin; 2007 Jun 04; 23(6):1303-18. PubMed ID: 17559729
    [Abstract] [Full Text] [Related]

  • 12. Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression.
    Henkel V, Seemüller F, Obermeier M, Adli M, Bauer M, Mundt C, Brieger P, Laux G, Bender W, Heuser I, Zeiler J, Gaebel W, Mayr A, Möller HJ, Riedel M.
    J Affect Disord; 2009 Jun 04; 115(3):439-49. PubMed ID: 19027961
    [Abstract] [Full Text] [Related]

  • 13. A randomized, double-blind, placebo-controlled trial of augmentation with an extended release formulation of methylphenidate in outpatients with treatment-resistant depression.
    Patkar AA, Masand PS, Pae CU, Peindl K, Hooper-Wood C, Mannelli P, Ciccone P.
    J Clin Psychopharmacol; 2006 Dec 04; 26(6):653-6. PubMed ID: 17110825
    [Abstract] [Full Text] [Related]

  • 14. A randomized, double-blind, placebo-controlled trial of desvenlafaxine succinate in the treatment of major depressive disorder.
    Septien-Velez L, Pitrosky B, Padmanabhan SK, Germain JM, Tourian KA.
    Int Clin Psychopharmacol; 2007 Nov 04; 22(6):338-47. PubMed ID: 17917552
    [Abstract] [Full Text] [Related]

  • 15. Is drug-placebo difference in short-term antidepressant drug trials on unipolar major depression much greater than previously believed?
    Rihmer Z, Gonda X.
    J Affect Disord; 2008 Jun 04; 108(3):195-8. PubMed ID: 18280581
    [Abstract] [Full Text] [Related]

  • 16. Assessing the efficacy of desvenlafaxine for improving functioning and well-being outcome measures in patients with major depressive disorder: a pooled analysis of 9 double-blind, placebo-controlled, 8-week clinical trials.
    Soares CN, Kornstein SG, Thase ME, Jiang Q, Guico-Pabia CJ.
    J Clin Psychiatry; 2009 Oct 04; 70(10):1365-71. PubMed ID: 19906341
    [Abstract] [Full Text] [Related]

  • 17. Patterns of depressive symptom response in duloxetine-treated outpatients with mild, moderate or more severe depression.
    Shelton RC, Prakash A, Mallinckrodt CH, Wohlreich MM, Raskin J, Robinson MJ, Detke MJ.
    Int J Clin Pract; 2007 Aug 04; 61(8):1337-48. PubMed ID: 17627710
    [Abstract] [Full Text] [Related]

  • 18. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder.
    Arnold LM, Lu Y, Crofford LJ, Wohlreich M, Detke MJ, Iyengar S, Goldstein DJ.
    Arthritis Rheum; 2004 Sep 04; 50(9):2974-84. PubMed ID: 15457467
    [Abstract] [Full Text] [Related]

  • 19. Gepirone extended-release treatment of anxious depression: evidence from a retrospective subgroup analysis in patients with major depressive disorder.
    Alpert JE, Franznick DA, Hollander SB, Fava M.
    J Clin Psychiatry; 2004 Aug 04; 65(8):1069-75. PubMed ID: 15323591
    [Abstract] [Full Text] [Related]

  • 20. Long-term effectiveness of cognitive therapy in major depressive disorder.
    Hensley PL, Nadiga D, Uhlenhuth EH.
    Depress Anxiety; 2004 Aug 04; 20(1):1-7. PubMed ID: 15368590
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.